Overview
Syndeio Biosciences is a biotechnology company developing a synapse pharmacology platform designed to identify and advance rapid-acting therapies for neurodegenerative diseases through precision neuroscience approaches including NMDA receptor modulation. The company leverages behavioral models and EEG analysis to accelerate drug discovery and enable targeted treatments for neurological disorders.
More in Neurotechnology
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics
2026-07-24 · Funding
Science Corp. Launches Prima BCI Implant in Europe, Bringing Vision Restoration to a New Market
2026-07-23 · Product
First Able-Bodied Individuals Receive Brain-Computer Implants in Landmark Expansion of BCI Eligibility
2026-07-22 · Research
Closed-Loop BCIs Charted as Next Frontier for Depression, Anxiety, and PTSD Treatment
2026-07-21 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →